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Currently, continuous processing for biologics is being pursued from a technology perspective in 
order to increase productivity and decrease cost of manufacture.  Disruptive technologies, such 
as PCC (Periodic Counter-current Chromatography), have been researched extensively in order 
to reduce the bottleneck for the downstream capture chromatography step.  However, there is 
extremely limited knowledge in how to scale these disruptive technologies for clinical and 
commercial manufacturing.  In this presentation, we demonstrate a strategy for scaling and 
integration of a PCC capture step into a semi-continuous downstream process (Protein A 
chromatography-Viral inactivation-Filtration-Anion exchange chromatography).   Harvest cell 
culture fluid (HCCF) feed streams ranging from  0.5 – 1 kg of various subclasses of IgG 
antibodies was purified using this integration process to generate material for toxicology studies.  
The process parameters on PCC for each mAb is matched to the process parameters in batch 
mode except for loading. The productivity (g/L-1 hr-1), product quality and yield are compared to 
the small scale semi-continuous operations and traditional batch mode operation. The use of 
PAT (Process Analytical Tools) for monitoring real time product quality and processing is also 
described.  
 
